6919 — Caliway Biopharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00- TWD251.25bn
- TWD241.85bn
- TWD44.43m
Annual cashflow statement for Caliway Biopharmaceuticals Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -98.4 | -224 | -286 | -488 | -589 |
| Depreciation | |||||
| Non-Cash Items | 12.7 | 77.6 | 15.3 | 6.06 | -8.82 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 20.2 | 12.7 | 2.76 | 30.6 | 45.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -47.2 | -111 | -243 | -424 | -522 |
| Capital Expenditures | -2.31 | -14.9 | -14.2 | -9.69 | -11.1 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | -456 | 167 | -2,478 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.31 | -14.9 | -471 | 157 | -2,489 |
| Financing Cash Flow Items | 20.7 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 123 | 627 | 772 | 3,034 | 6,491 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 71.9 | 501 | 60.1 | 2,767 | 3,479 |